Goldman Sees Execution As Key For Allergan (AGN) In 2017
Tweet Send to a Friend
Goldman Sachs maintains Buy on Allergen (NYSE: AGN) price target of $250.00 (from $240.00).Analyst Jami Rubin comments "With ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE